Nomination Committee’s proposal for Board of Directors of Asker ahead of the 2026 Annual General Meeting
The Nomination Committee of Asker Healthcare Group AB (publ) (“Asker”) proposes that Mikael Stöhr be elected as new Chair and member of the Board of Directors, and that Joachim Zetterlund be elected as new member of the Board of Directors at the Annual General Meeting on 7 May 2026. Asker’s current Chair of the Board, Håkan Björklund, has declined re-election due to a desire to reduce the number of assignments. Board member Martin Lagerblad has also declined re-election. The Nomination Committee proposes re-election of the other Board members Birgitta Stymne Göransson, Karl Petersson, Mikael Vinje and Nina Linander.
“Mikael Stöhr has extensive experience from both board work and operational roles in various industries and is a widely recognised and highly skilled leader. Mikael and Joachim, together with the other board members, will form an experienced and strong Board well suited to continue driving the company’s growth journey,” says Johan Hesser, Chair of the Nomination Committee of Asker.
Mikael Stöhr, born in 1970, is currently Chair of the Board of Coor and Hjo Installation and Board member of Werksta Group. He has board experience from several companies, including Ambea and SJ. Mikael also has many years of experience in leading companies, including as CEO of Coor, Consolis Group, Green Cargo and AxIndustries.
Joachim Zetterlund, born in 1963, is currently a Board member of Allurity, iLOQ and FörlagsSystem JAL and has broad experience of leading several companies in various industries.
The Nomination Committee would like to express its warm thanks to Håkan Björklund, who has served as Chair of the Board since 2019, and to Martin Lagerblad, who has served as a Board member since 2021, for their significant contributions and leadership during Asker’s rapid growth journey. Their experience in creating a stable platform for growth has been valuable as Asker has evolved from an unlisted company with a Nordic focus into a listed pan-European player by combining organic growth with a large number of acquisitions. Håkan’s extensive experience and stable leadership have been particularly appreciated during his tenure as Chair of the Board.
The Nomination Committee of Asker consists of representatives of the company’s three largest shareholders, who together represent approximately 49.7 percent of the shares and votes, as well as the Chair of the Board, Håkan Björklund. The members representing the largest shareholders are Johan Hesser (Interogo Long-Term Equity), Patrik Jönsson (SEB Funds AB) and Richard Torgerson (Nordea Funds).
The Nomination Committee’s complete proposals will be published in the notice to attend the 2026 Annual General Meeting.
For further information, please contact:
Emma Rheborg, Head of Communication Asker Healthcare Group
Phone: +46 73 313 62 17
E-mail: [email protected]
Asker Healthcare Group is a partner to caregivers and patients across Europe providing medical products and solutions. We build and acquire leading companies that together support the healthcare system to improve patient outcomes, reduce total cost of care and ensure a fair and sustainable value chain. We are a European healthcare group that combines the entrepreneurial drive of strong local companies, with the abilities and collected knowledge of a large group – driving progress in the healthcare sector. The group has more than 4 500 employees in 19 countries and revenues amounting to SEK 17 billion.